Magdalena Jonikas

Invests in

BiotechHealthtechMedical Devices

Investments

Per the firm's website.

Colleagues at Jeito Capital

AR

Alain Rougon

Chief Financial Officer (external provider, Prodensia) at Jeito Capital

AS

Anastasiya Sybirna

Principal at Jeito Capital

AC

Annette Clancy

Pharma M&A Strategy at Jeito Capital

AR

Arnaud Rousseau

Asset Manager at Ginkgo Advisor Sarl

BC

Benjamin Caillier

Finance Director, Jeito Capital at Jeito Capital

BK

Boris Kere

Compliance Officer at Jeito Capital

CF

Charlotte Formont

Senior Legal Counsel at Jeito Capital

CM

Chloé Morlaàs

Investor Relations Director at Jeito Capital

Frequently asked questions

Who is Magdalena Jonikas?

Magdalena Jonikas has 15 years of experience in international biopharma across strategy, investing, and operations. At Syncona Ltd., she led the creation and strategic development of therapeutics companies including OMass Therapeutics, Kesmalea Therapeutics, and Mosaic Therapeutics, serving as investor director on portfolio boards and interim CEO of Mosaic Therapeutics. Previously, she was an Associate Partner at McKinsey & Company advising global pharmaceutical and healthcare clients on strategy and commercial due diligence across therapeutics, medtech, and services.

Where does Magdalena Jonikas work?

Magdalena Jonikas is Partner at Jeito Capital.

What does Magdalena Jonikas invest in?

Magdalena Jonikas invests in Biotech, Healthtech, Medical Devices.

What boards does Magdalena Jonikas sit on?

Magdalena Jonikas holds tracked board seats at Mosaic Therapeutics.

What companies has Magdalena Jonikas invested in?

Investments tracked here include Kesmalea Therapeutics, OMass Therapeutics.

Where did Magdalena Jonikas go to school?

Magdalena Jonikas studied at Stanford University (PhD, Bioengineering); Stanford University (MS, Bioengineering); University of Pennsylvania (BSE, Bioengineering).

Does Magdalena Jonikas lead rounds?

Yes — Magdalena Jonikas has led 2 tracked investments.